Population pharmacokinetics of tenofovir in HIV-1-infected pregnant women and their neonates (ANRS 12109). - Wikidata - wikimedia - TriplyDB

Population pharmacokinetics of tenofovir in HIV-1-infected pregnant women and their neonates (ANRS 12109).

Population pharmacokinetics of tenofovir in HIV-1-infected pregnant women and their neonates (ANRS 12109).

http://www.wikidata.org/entity/Q46261840

about

Pregnancy-Associated Changes in Pharmacokinetics: A Systematic Review Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial Placental transfer of darunavir in an ex vivo human cotyledon perfusion model.Efficacy and safety of tenofovir disoproxil fumarate in patients with chronic hepatitis B.Protecting the fetus against HIV infection: a systematic review of placental transfer of antiretrovirals.Population pharmacokinetics of nevirapine in HIV-1-infected pregnant women and their neonates.Concentrations of tenofovir and emtricitabine in breast milk of HIV-1-infected women in Abidjan, Cote d'Ivoire, in the ANRS 12109 TEmAA Study, Step 2 Health needs of HIV-infected women in the United States: insights from the women living positive survey.Plasma and intracellular tenofovir pharmacokinetics in the neonate (ANRS 12109 trial, step 2)Tenofovir rescue therapy in pregnant females with chronic hepatitis B Pharmacokinetics and safety of single-dose tenofovir disoproxil fumarate and emtricitabine in HIV-1-infected pregnant women and their infants Pregnancy-related effects on tenofovir pharmacokinetics: a population study with 186 women.Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202 Meconium Tenofovir Concentrations and Growth and Bone Outcomes in Prenatally Tenofovir Exposed HIV-Uninfected Children Model Linking Plasma and Intracellular Tenofovir/Emtricitabine with Deoxynucleoside Triphosphates.Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infants Pharmacokinetic studies in infants using minimal-risk study designs Prediction of human fetal pharmacokinetics using ex vivo human placenta perfusion studies and physiologically based models.Pharmacokinetics of tenofovir during pregnancy and postpartum.Population Pharmacokinetics of Tenofovir in HIV-1-Uninfected Members of Serodiscordant Couples and Effect of Dose Reporting Methods.Estimation of tenofovir's population pharmacokinetic parameters without reliable dosing histories and application to tracing dosing history using simulation strategies.Infant growth outcomes after maternal tenofovir disoproxil fumarate use during pregnancy.Pharmacokinetics and safety of tenofovir in HIV-infected women during labor and their infants during the first week of life.Obstetric Pharmacokinetic Dosing Studies are Urgently Needed.A review of nucleoside reverse transcriptase inhibitor use to prevent perinatal transmission of HIV.Chronic hepatitis B virus infection and pregnancy.Pharmaceutical characterization of novel tenofovir liposomal formulations for enhanced oral drug delivery: in vitro pharmaceutics and Caco-2 permeability investigations Anticoagulating obese patients in the modern era.Pharmacokinetic optimization of antiretroviral therapy in pregnancy.Population pharmacokinetic analysis during the first 2 years of life: an overview.Basic obstetric pharmacology.British HIV Association guidelines for the management of HIV infection in pregnant women 2012 (2014 interim review).NRTI backbone in HIV treatment: will it remain relevant?Pharmacokinetic profiling of efavirenz-emtricitabine-tenofovir fixed dose combination in pregnant and non-pregnant rats.Effect of a Roux-en-Y gastric bypass on the pharmacokinetics of oral morphine using a population approach.A Physiologically-Based Pharmacokinetic Model to Predict Human Fetal Exposure for a Drug Metabolized by Several CYP450 Pathways.Tenofovir and tenofovir-diphosphate concentrations during pregnancy among HIV-uninfected women using oral preexposure prophylaxis British HIV Association guidelines for the management of HIV infection in pregnant women 2012

P2860

Q28109657-1CE282CA-3C2F-423C-B551-40583033AEC8 Q28483723-408F630D-3705-4FC0-9D19-D4BEE6223E0A Q34057304-AD491477-50A6-4475-9B53-6EC6C5D1483D Q34409132-7E1FAD98-6372-49BF-B07D-A60016E0B857 Q34429204-07EAEA6C-D84B-4E32-94C6-550222471492 Q34483505-D492F5C6-4FCC-466C-B180-8B07C71A184E Q34737231-8814A463-CB72-4ECA-B8D0-9EF3A03DD017 Q34904319-1C07E1E5-DA12-4940-AEEB-D70695173884 Q35005051-6F79B356-BCF7-4883-B503-7C2C519BC264 Q35128259-0884B0DD-28E2-44DF-8D94-4747AEEEFFC7 Q35598502-C73D357D-C50B-4740-856E-0B69DB5DC63A Q35689404-66636E52-B1B5-4CE1-9E1B-D0EB3A411E5E Q35908584-54D87906-430C-43B8-AA06-B93AAF618E08 Q36070335-1881A885-9E47-48AF-B9C1-818599744915 Q36188725-02D8E467-CCD5-437A-B996-A41E8F63EB18 Q36333957-467AA132-5BAD-459D-8658-A8EECA0F1DDF Q36438116-518B47C0-0F7C-47E5-BD2E-283369558450 Q36706781-A9CC1363-2418-4616-A93E-3BEFFEA22F68 Q36888597-8A9153A5-26BD-4B83-9D25-0A4540638398 Q37203867-947B2317-FA47-4521-AB5D-13178FBD3F74 Q37210864-7FD170CA-D8AF-414B-B19C-740558FD6D29 Q37283062-004BBC11-F72A-491D-9B14-2C5581B964B4 Q37551251-32994C90-F893-4D48-928A-F259EB66D6C7 Q37575742-2D8B9982-5D1C-4A80-9F43-7852699CC2C8 Q37588728-11A9FDFF-161E-4844-BE3B-0D8232CEF5FB Q37613468-C4ED9192-DAE9-4597-8556-7E84BFCB5339 Q37669191-BE77938C-D559-436B-9714-B66AAF4807B3 Q37919151-AB32080B-4039-49FA-B06C-9964BBE99103 Q38047214-51E0FFEC-1DC3-48E0-B613-76159C62BE97 Q38062388-AB0B55C0-7F8B-42A2-B0E4-9463E0031FED Q38256590-4B8240ED-2DDA-40D7-B3E3-593ECE85D1D6 Q38325427-216BF67E-8653-41DB-8934-FEC73B95D4BF Q39533858-CBC9BFA0-58F8-43E0-AD6D-2074473A92A7 Q43475720-02EB8A7A-DFC6-4891-BA93-0F7CE81543C6 Q48035659-81347F11-46F1-4633-A99F-656617F14424 Q48072950-4814C08B-6069-41B6-86FD-1DAE30A330BD Q56910156-6A355622-E87B-480D-B933-CFF58F85C83F Q57076282-B9A25FE6-9FDB-438B-8613-F2D33E22BDA8

P2860

Population pharmacokinetics of tenofovir in HIV-1-infected pregnant women and their neonates (ANRS 12109).

http://www.wikidata.org/entity/Q46261840

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Population pharmacokinetics of ...... d their neonates (ANRS 12109).

@en

Population pharmacokinetics of ...... gnant women and their neonates

@nl

type

label

Population pharmacokinetics of ...... d their neonates (ANRS 12109).

@en

Population pharmacokinetics of ...... gnant women and their neonates

@nl

prefLabel

Population pharmacokinetics of ...... d their neonates (ANRS 12109).

@en

Population pharmacokinetics of ...... gnant women and their neonates

@nl

P1433

Q46261840-BFE96641-626B-4F10-97D9-8919BCBB0EB7

P1476

Q46261840-3225D7BB-844A-4E8F-AF33-E5AC33C82CAC

P2093

Q46261840-0957E418-5629-49BE-9C9A-D453009D6CC7

Q46261840-17693CC3-4512-4F3B-B73C-23F7315ACED0

Q46261840-2937E0FF-D16E-4C8C-B570-CD8979268283

Q46261840-509E2C43-52DE-4229-B565-A46288A62747

Q46261840-608D42E0-E9EB-4198-8C19-41E191F155EB

Q46261840-66465804-60CD-4B41-8C0C-6C4A88EDBD0F

Q46261840-6711BF8D-2069-4858-BB7B-1B6AEC4BEA26

Q46261840-71ACF4F6-5EC4-4094-8596-7DF0242D3E9B

Q46261840-90F63536-6798-478C-93E4-D1FD7D620266

Q46261840-A1936DBB-73CA-4659-A3D7-F2E58442E459

P2860

Q46261840-04AC7062-7CAE-4E00-98A7-ECB4E8221AC6

Q46261840-0C122FD1-79F8-4085-BF53-A2C3A030AB36

Q46261840-207C4EBE-007A-4116-87E3-551F579CA442

Q46261840-36F929D4-2D0E-4097-BAB0-94799B1F7BC6

Q46261840-3A88BEB4-52E8-4878-AA4B-F63320ADD047

Q46261840-3E52EA97-7409-49C4-92E8-10A2EE6AFA4D

Q46261840-511517D5-F4A5-4052-B340-090ED389151E

Q46261840-6B447F2E-971D-4A37-85B8-0F4E85227923

Q46261840-6DCB5DD9-0575-42EE-91B1-4776850C58B4

Q46261840-7337C79D-5371-4383-9B09-54DB08B57225

P2888

Q46261840-161FFE2E-2923-460D-BA96-1DF70DD61F7A

P304

Q46261840-A55C9BE8-A697-48C8-A0B5-96074C595797

P31

Q46261840-022846F6-1280-4866-9CF2-0CDC873B5107

P356

Q46261840-924905E4-EBDB-4854-9229-40857230E7D7

P407

Q46261840-9889B6A0-C16B-462B-B338-2A96E50ED3F9

P433

Q46261840-142802E3-8F3A-4E3E-8F4B-769D40ACC434

P478

Q46261840-93CF8304-E715-4C6C-A1CF-98222728E10B

P50

Q46261840-907A41C6-5BCD-43CF-9347-07F9F88A6052

P577

Q46261840-2A40F4AE-C941-471E-AD9A-EB04C1D26FD3

P5875

Q46261840-C23CF302-2C00-47FB-A4A7-EF12849121F7

P6179

Q46261840-A9D591B7-592D-4951-BCA0-5F65F2B6B150

P698

Q46261840-03736F46-5AFC-44AD-967D-8D8910A82F96

P921

Q46261840-FF5FC03C-18B5-4845-BBE3-94BFB9EF6FE0

P356

P1433

Clinical Pharmacology & Therapeutics

P1476

Population pharmacokinetics of ...... d their neonates (ANRS 12109).

@en

P2093

ANRS 12109

http://www.w3.org/2001/XMLSchema#string

C Amani-Bosse

http://www.w3.org/2001/XMLSchema#string

D Hirt

http://www.w3.org/2001/XMLSchema#string

D K Ekouévi

http://www.w3.org/2001/XMLSchema#string

E Arrivé

http://www.w3.org/2001/XMLSchema#string

E Nerrienet

http://www.w3.org/2001/XMLSchema#string

E Rey

http://www.w3.org/2001/XMLSchema#string

G Gray

http://www.w3.org/2001/XMLSchema#string

J McIntyre

http://www.w3.org/2001/XMLSchema#string

J-M Tréluyer

http://www.w3.org/2001/XMLSchema#string

P2860

Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice.

Ways to fit a PK model with some data below the quantification limit.

Population pharmacokinetics of tenofovir in human immunodeficiency virus-infected patients taking highly active antiretroviral therapy.

Tenofovir disoproxil fumarate: a review of its use in the management of HIV infection.

HIV-1/AIDS and maternal and child health in Africa.

Pharmacokinetics in the newborn.

Ontogeny of drug elimination by the human kidney.

Pharmacokinetic modelling of the placental transfer of nelfinavir and its M8 metabolite: a population study using 75 maternal-cord plasma samples.

Organic anion transporter family: current knowledge.

Molecular insights into the structure-function relationship of organic anion transporters OATs.

P2888

P304

182-189

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/CLPT.2008.201

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P50

François Dabis

P577

2008-11-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232780873

http://www.w3.org/2001/XMLSchema#string

P6179

1008665565

http://www.w3.org/2001/XMLSchema#string

P698

18987623

http://www.w3.org/2001/XMLSchema#string

P921